Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Gilead Sciences (GILD) announces a deal to purchase Pharmasset (VRUS) for $11B in a deal that is...

  • Monday, November 21, 2011, 7:17 AM ET
    Gilead Sciences (GILD) announces a deal to purchase Pharmasset (VRUS) for $11B in a deal that is expected to close in Q1 and become accretive to Gilead's earnings starting in 2015. The $137/share offer price agreed upon by the firms marks an 89% premium to the closing price of Pharmasset on Friday.
Track new comments on this story

This news story has 2 comments:

  •  
    What if you owned more GILD than VRUS? Some folks did. http://bit.ly/svFPCi
    21 Nov 2011, 09:43 AM Reply Like
  •  
    Is $GILD undervalued? See F.A.S.T. Graphs: http://bit.ly/vfyDTX
    21 Nov 2011, 11:45 AM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)
Latest Articles
More Latest Articles »